Mobia Medical, having recently completed its IPO in May 2026, filed its inaugural quarterly 10-Q indicating $12.1 million in revenue alongside a net loss of $17.7 million for the quarter ended March 31, 2026. The company’s balance sheet shows strong liquidity ratios that provide operational runway as it navigates early commercial scaling. Concurrently, Mobia formalized comprehensive governance restructuring via amended certificate of incorporation and bylaws featuring a classified board and exclusive forum provisions designed to reinforce organizational stability. Despite scarce specifics on products or market segments, these developments mark critical steps toward building the operational and structural backbone needed to translate early-stage investment into sustainable growth.